mHealth Futures is proud to be innovation lead for the EmERGE project developing mHealth solutions for the management of stable HIV. We are a member of a consortia of 12 organisations across Europe with clinical sites in Antwerp, Barcelona, Brighton, Lisbon and Zagreb.
EmERGE (Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and Innovation to Generate Evidence for personalised care) is a project funded by the European Union’s Horizon 2020 Researcher and Innovation Programme under Grant agreement no: 643736.
With our partners we are developing a mHealth platform under the Acesso brand to enable self-management of HIV in patients with stable disease. The platform builds upon and integrates the existing mhealth solutions operated by pioneering healthcare providers in the UK and Spain and applies a rigorous co-design approach to ensure patient and clinician input to the solution.
The platform provides users with web based and mobile device applications which interface securely with relevant medical data and facilitates remote access to key healthcare providers. EATG, the European HIV patient organisation, provides a direct and deep interaction with representative patients and clinicians from 5 EU countries.
The platform and interfaces are being validated in a large study of 3900 patients using a tailored HTA process, MAST, specifically developed for the assessment of mHealth solutions including translatability as a key factor.